Ovixan (Mometasone Furoate)

Mometasone furoate, the active ingredient in Ovixan, is a corticosteroid presented as a topical formulation for dermatological use. It treats inflammatory skin conditions such as eczema, psoriasis and allergic dermatitis in adult and pediatric patients. GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ovixan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ovixan is a corticosteroid that acts on inflammatory pathways of the skin.

- Eczema: Reduces redness, itching and swelling associated with atopic dermatitis. - Psoriasis: Helps to control plaque formation and scaling. - Allergic dermatitis: Alleviates inflammation caused by contact allergens. - Seborrheic dermatitis: Decreases scalp irritation and flaking. - Lichen planus: Provides symptomatic relief of lesions.

Adverse reactions may vary depending on the duration of therapy and the area of skin treated.

Common Side Effects: - Burning sensation - Itching - Dryness - Redness - Folliculitis - Skin thinning (atrophy)

Serious or Rare Side Effects: - Secondary infection of the skin - Hypersensitivity reactions - Severe skin atrophy - Systemic cortisol suppression - Hypertrichosis - Delayed wound healing

When ​ ​  ​  ​     ​     ​  …     ​  … …  …  …  …  …  … … … … … … … … … … … … … … … … …

-  00   t   \\  ...   ewline \\  y  \